APPLICATION OF ANALYTICAL HIERARCHY PROCESS FOR COMPARING VORTIOXETINE TO AGOMELATINE AND VENLAFAXINE XR IN MAJOR DEPRESSIVE DISORDER

被引：0
|
作者：
Briquet, B. [1 ]
Diamand, F. [2 ]
Francois, C. [3 ]
Brignone, M. [4 ]
机构：
[1] Benjamin BRIQUET, Levoncourt, France
[2] Lundbeck SAS, Paris, France
[3] Lundbeck, Deerfield, IL USA
[4] Lundbeck SAS, Issy Les Moulineaux, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH8
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [31] Effectiveness and tolerability of vortioxetine for major depressive disorder
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Navarro, R.
    Santamaria, O.
    Gotor Sanchez-Luengo, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S847 - S848
  • [32] Vortioxetine: a New Treatment for Major Depressive Disorder
    Connolly, K. Ryan
    Thase, Michael E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) : 421 - 431
  • [33] The efficacy of vortioxetine for the treatment of major depressive disorder
    Dhir, Ashish
    Sarvaiya, Jayrajsinh
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (12) : 1349 - 1363
  • [34] The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine
    Francois, Clement
    Nielsen, Rebecca
    Danchenko, Natalya
    Williams, Valerie
    Lancon, Christophe
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (06) : 1057 - 1066
  • [35] Major Depressive Disorder, sleep EEG and agomelatine
    Quera Salva, M.
    Vanier, B.
    Laredo, J.
    Moulin, C.
    Chapotot, F.
    Lofaso, F.
    Christian, G.
    SLEEP, 2006, 29 : A325 - A326
  • [36] Venlafaxine XR treatment for older patients with major depressive disorder: decision trees for when to change treatment
    Kim, Helena Kyunghee
    Blumberger, Daniel M.
    Karp, Jordan F.
    Lenze, Eric
    Reynolds, Charles F.
    Mulsant, Benoit H.
    EVIDENCE-BASED MENTAL HEALTH, 2022, 25 (04) : 156 - 162
  • [37] Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea
    Choi, Sang-Eun
    Brignone, Melanie
    Cho, Seong Jin
    Jeon, Hong Jin
    Jung, Rangrhee
    Campbell, Rosanne
    Francois, Clement
    Milea, Dominique
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (05) : 629 - 638
  • [38] Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial
    Manna, Chayan K.
    Ranjan, Rajeev
    Kumar, Pankaj
    Ahmad, Shamshad
    Nath, Santanu
    INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 (08) : 815 - 824
  • [39] Efficacy of vortioxetine on the physical symptoms of major depressive disorder
    Christensen, Michael Cronquist
    Florea, Ioana
    Lindsten, Annika
    Baldwin, David S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (10) : 1086 - 1097
  • [40] Venlafaxine versus sertraline for major depressive disorder
    Wise, TN
    Sheridan, MJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (11) : 873 - 874
12345